Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest news stories, live from Hawaiian Eye.

• Welcome to the Eyeluminaries podcast :01
• Review of episode 10, the Allergan alumni guests 1:30
• Bausch + Lomb announces acquisition of AcuFocus 3:39
• Mazzo attributes success to people and the magic of ophthalmology 5:40
• Keranova’s PhotoEmulsification technique shows promising results 9:25
• Centricity CEO discusses latest cataract surgery products 11:04
• Orasis submits new drug application for presbyopia drop 12:30
• Aldeyra submits NDA for primary vitreoretinal lymphoma treatment 15:27
• Iveric Bio submits final part of Zimura new drug application for rolling review 17:30
• Tom Frinzi to become CEO of STAAR Surgical 22:37
• Wrap up and a preview of episode 12 25:38
• Feedback, questions and guest suggestions at [email protected] 27:39
• Thanks for listening 28:00

John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California.

Jim Mazzo sits on numerous ophthalmic industry corporate boards and committees after serving in executive roles with Allergan, Avellino Labs, Carl Zeiss and AMO.

We’d love to hear from you! Send your comments/questions to [email protected]. Follow John Hovanesian on Twitter @DrHovanesian.

Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an adviser for Zeiss, Bain Capital, Avellino Labs, CVC Capital, Anivive Lifesciences; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Lensgen, IanTech, Centricity Vision and Visus.